Developing mRNA lipid nanoparticle vaccine effective for cryptococcosis in a murine model

被引：0
|
作者：
Li, Yeqi [1 ]
Ambati, Suresh [2 ]
Meagher, Richard B. [2 ]
Lin, Xiaorong [1 ]
机构：
[1] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA
[2] Univ Georgia, Dept Genet, Athens, GA 30602 USA
来源：
NPJ VACCINES | 2025年 / 10卷 / 01期
关键词：
DNA VACCINE; POLYSACCHARIDE;
D O I：
10.1038/s41541-025-01079-z
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Cryptococcus neoformans is considered a critical fungal pathogen by the World Health Organization and developing a vaccine for cryptococcosis is a top priority. Here, we employed mRNAs encoding an antigen(s) packaged in lipid nanoparticles (LNPs) to develop vaccines for cryptococcosis. Remarkably, when coupled with capsule adjuvant, vaccination with CDA1-LNPs protected the vast majority of mice from the otherwise lethal cryptococcosis. These results support the promise of mRNA-LNP vaccines against fungal diseases.
引用
收藏
页数：7
相关论文
共 50 条
  • [1] Developing an influenza vaccine using lipid nanoparticle-encapsulated nucleoside-modified mRNA
    Pardi, N.
    Naradikian, M. S.
    Parkhouse, K.
    Hensley, S. E.
    Cancro, M. P.
    Weissman, D.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 1232 - 1233
  • [2] Principles for designing an optimal mRNA lipid nanoparticle vaccine
    Kon, Edo
    Elia, Uri
    Peer, Dan
    CURRENT OPINION IN BIOTECHNOLOGY, 2022, 73 : 329 - 336
  • [3] Impact of lipid nanoparticle size on mRNA vaccine immunogenicity
    Hassett, Kimberly J.
    Higgins, Jaclyn
    Woods, Angela
    Levy, Becca
    Xia, Yan
    Hsiao, Chiaowen Joyce
    Acosta, Edward
    Almarsson, Orn
    Moore, Melissa J.
    Brito, Luis A.
    JOURNAL OF CONTROLLED RELEASE, 2021, 335 : 237 - 246
  • [4] Future considerations for the mRNA-lipid nanoparticle vaccine platform
    Igyarto, Botond Z.
    Jacobsen, Sonya
    Ndeupen, Sonia
    CURRENT OPINION IN VIROLOGY, 2021, 48 : 65 - 72
  • [5] Development of an mRNA-lipid nanoparticle vaccine against Lyme disease
    Pine, Matthew
    Arora, Gunjan
    Hart, Thomas M.
    Bettini, Emily
    Gaudette, Brian T.
    Muramatsu, Hiromi
    Tombacz, Istvan
    Kambayashi, Taku
    Tam, Ying K.
    Brisson, Dustin
    Allman, David
    Locci, Michela
    Weissman, Drew
    Fikrig, Erol
    Pardi, Norbert
    MOLECULAR THERAPY, 2023, 31 (09) : 2702 - 2714
  • [6] A Cocktail of Lipid Nanoparticle-mRNA Vaccines Broaden Immune Responses against β-Coronaviruses in a Murine Model
    Zhang, Yi
    Zhang, Jialu
    Li, Dongmei
    Mao, Qunying
    Li, Xiuling
    Liang, Zhenglun
    He, Qian
    VIRUSES-BASEL, 2024, 16 (03):
  • [7] Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine
    LaTourette, Philip C., II
    Awasthi, Sita
    Desmond, Angela
    Pardi, Norbert
    Cohen, Gary H.
    Weissman, Drew
    Friedman, Harvey M.
    VACCINE, 2020, 38 (47) : 7409 - 7413
  • [8] A lipid nanoparticle platform incorporating trehalose glycolipid for exceptional mRNA vaccine safety
    Bae, Seo-Hyeon
    Yoo, Soyeon
    Lee, Jisun
    Park, Hyo-Jung
    Kwon, Sung Pil
    Jin, Harin
    Park, Sang-In
    Lee, Yu-Sun
    Bang, Yoo-Jin
    Roh, Gahyun
    Lee, Seonghyun
    Youn, Sue Bean
    Kim, In Woo
    Oh, Ho Rim
    El-Damasy, Ashraf K.
    Keum, Gyochang
    Kim, Hojun
    Youn, Hyewon
    Nam, Jae-Hwan
    Bang, Eun-Kyoung
    BIOACTIVE MATERIALS, 2024, 38 : 486 - 498
  • [9] mRNA vaccine against malaria effective in preclinical model
    Makoni, Munyaradzi
    LANCET MICROBE, 2023, 4 (12): : E970 - E970
  • [10] Effective Transcatheter Intracoronary Delivery of mRNA-Lipid Nanoparticle Targeting on The Heart
    Handa, Kazuma
    Kawamura, Masashi
    Sasai, Masao
    Matsuzaki, Takashi
    Harada, Akima
    Miki, Kenji
    Fujimura, Lisa
    Saito, Shunsuke
    Tsuneda, Ryo
    Fujishiro, Anri
    Hirano, Kunio
    Miyagawa, Shigeru
    CIRCULATION, 2024, 150
12345